Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine

Journal of Neuroscience

Volumn 21, Issue 12, 2001, Pages 4427-4435

  Tillerson, J L ^a   Cohen, A D ^a   Philhower, J ^a   Miller, G W ^a   Zigmond, M J ^a   Schallert, T ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Dopamine; Motor therapy; Movement; Neurodegeneration; Parkinson's disease; Plasticity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; APOMORPHINE; DOPAMINE; HOMOVANILLIC ACID; OXIDOPAMINE;

AKINESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DEGENERATIVE DISEASE; DOPAMINE METABOLISM; IMMOBILIZATION; LIMB MOVEMENT; MALE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PHYSIOTHERAPY; PLASTER CAST; PRIORITY JOURNAL; RAT;

EID: 0035875912     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-12-04427.2001     Document Type: Article

References (96)

1. Establishing physical objectives in rehabilitation of patients with Parkinson's disease (gymnasium activities)
2. Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings)
3. Movement-related glutamate levels in rat hippocampus, striatum, and sensorimotor cortex
4. Early exclusive use of the affected forelimb after moderate transient focal ischemia in rats: Functional and anatomic outcome
5. Catecholamines, dopamine, and endorphin levels during extreme exercise
6. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: Morphological and biochemical effects
7. Reactive astrocytic responses to denervation in the motor cortex of adult rats are sensitive to manipulations of behavioral experience
8. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity
9. Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area
10. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor
11. The effect of temperature and anesthesia on the unilateral 6-OHDA model in the rat
12. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged parkinsonian rat
13. Tactile impoverishment and sensorimotor restriction deteriorate the forepaw cutaneous map in the primary somatosensory cortex of adult rats
14. Parkinsonism and levodopa: A five-year experience
15. Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues
16. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP
17. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists
18. Aging and Parkinson's disease: Substantia nigra regional selectivity
19. Physiotherapy in Parkinson's disease
20. Regional brain dopamine metabolism: A marker for the speed, direction, and posture of moving animals
21. Mammalian neural stem cells
22. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: Neuropsychological and neurological side effects. Report of four cases and review of the literature
23. Spatial learning and physical activity contribute to the induction of fibroblast growth factor: Neural substrates for increased cognition associated with exercise
24. Lesion-induced proliferation of neuronal progenitors in the dentate gyrus of the adult rat
25. Learning enhances adult neurogenesis in the hippocampal formation
26. Neurogenesis in the neocortex of adult primates
27. Circling behavior in rats with partial unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA
28. Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment
29. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period
30. Use-dependent exaggeration of brain injury: Is glutamate involved?
31. The benefit of a home exercise regimen for ambulatory Parkinson's disease patients
32. Physiological consequences of morphologically detectable synaptic plasticity: Potential uses for examining recovery following damage
33. Acute effect of exercise on human blood platelet serotonin uptake and monoamine oxidase activity
34. Use-dependent growth of pyramidal neurons after neocortical damage
35. Environmental stimulation of 129/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyms
36. Experience-induced neurogenesis in the senescent dentate gyrus
37. 11C]tetrabenazine and positron emission tomography
38. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
39. Synaptogenesis and fos expression in the motor cortex of the adult rat after motor skill learning
40. Synaptic plasticity in cortical systems
41. Report of case of parkinsonism treated with proprioceptive facilitation techniques
42. Brain plasticity and behavior
43. Relationship between dendritic pruning and behavioral recovery following sensorimotor cortex lesions
44. Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions
45. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections
46. Selective brain cooling increases cortical cerebral blood flow in rats
47. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
48. When did Ray Kennedy's Parkinson's disease begin?
49. Treatment-induced cortical reorganization after stroke in humans
50. Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio barpressing task
51. Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats
52. Levodopa-induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
53. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels
54. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats
55. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration
56. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease
57. Hemiparkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height
58. Skilled reaching deficits in unilateral dopamine-depleted rats: Impairments in movement and posture and compensatory adjustments
59. Impairments and compensatory adjustments in spontaneous movement after unilateral dopamine depletion in rats
60. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease
61. Dopamine transporters and neuronal injury
62. Effects of reducing sensory-motor feedback on the appearance of crossed nigro-thalamic projections and recovery from turning induced by unilateral substantia nigra lesions
63. Exercise and brain neurotrophins
64. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: Relationship to recovery of sensorimotor functions and behavioral supersensitivity
65. Etiology and pathogenesis of Parkinson's disease
66. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
67. Exercise therapy for Parkinson's disease
68. Early training may exacerbate brain damage after focal brain ischemia in the rat
69. The rotational behavior model: Asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats
70. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats
71. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts
72. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease
73. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle
74. The role of physical exercise in the occurrence of Parkinson's disease
75. Aging-dependent emergence of sensorimotor dysfunction in rats recovered from dopamine depletion sustained early in life
76. "Disengage" sensorimotor deficit following apparent recovery from unilateral dopamine depletion
77. Intervention strategies for degeneration of dopamine neurons in Parkinsonism: Optimizing behavioral assessment of outcome
78. Neurotransmitter-selective brain lesions
79. The postures of catecholamine-depletion catalepsy: Their possible adaptive value in thermoregulation
80. Pharmacologic and anatomic considerations in recovery of function
81. Use-dependent structural events in recovery of function
82. Motor rehabilitation, use-related neural events, and reorganization of the brain after injury
83. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
84. Experience-associated structural events, subependymal cellular proliferative activity, and functional recovery after injury to the central nervous system
85. Depletion of dopamine in the striatum as an experimental model of Parkinsonism: Direct effects, adaptive mechanisms
86. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery, and treatments
87. Motor learning and Parkinson's disease: Refinement of within-limb and between-limb coordination as a result of practice
88. Adjunctive treatment in Parkinson's disease: Physical therapy and comprehensive group therapy
89. Constraint-induced movement therapy: A new family of techniques with broad application to physical rehabilitation - A clinical review
90. The effects of a balance and strength training program on equilibrium in parkinsonism: A preliminary study
91. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system
92. Running enhances neurogenesis, learning, and long-term potentiation in mice
93. Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat
94. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism
95. Parkinson's disease: Studies with an animal model
96. Animal models of parkinsonism using selective neurotoxins: Clinical and basic implications